Probi AB Net Income vs. Revenue

PROB Stock  SEK 347.00  1.00  0.29%   
Based on the measurements of profitability obtained from Probi AB's financial statements, Probi AB may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Probi AB's ability to earn profits and add value for shareholders.
For Probi AB profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Probi AB to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Probi AB utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Probi AB's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Probi AB over time as well as its relative position and ranking within its peers.
  
Check out Your Equity Center.
Please note, there is a significant difference between Probi AB's value and its price as these two are different measures arrived at by different means. Investors typically determine if Probi AB is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Probi AB's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Probi AB Revenue vs. Net Income Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Probi AB's current stock value. Our valuation model uses many indicators to compare Probi AB value to that of its competitors to determine the firm's financial worth.
Probi AB is considered to be number one stock in net income category among its peers. It also is rated top company in revenue category among its peers totaling about  7.92  of Revenue per Net Income. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Probi AB's earnings, one of the primary drivers of an investment's value.

Probi Revenue vs. Net Income

Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Probi AB

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

 = 
83.14 M
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Probi AB

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
658.18 M
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

Probi Revenue vs Competition

Probi AB is rated top company in revenue category among its peers. Market size based on revenue of Health Care industry is at this time estimated at about 699.97 Million. Probi AB totals roughly 658.18 Million in revenue claiming about 94% of equities under Health Care industry.

Probi AB Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Probi AB, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Probi AB will eventually generate negative long term returns. The profitability progress is the general direction of Probi AB's change in net profit over the period of time. It can combine multiple indicators of Probi AB, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Probi AB , a bioengineering company, researches, develops, manufactures, markets, and sells probiotics for food, health, and pharmaceutical companies. The company was founded in 1991 and is headquartered in Lund, Sweden. Probi AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 164 people.

Probi Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Probi AB. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Probi AB position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Probi AB's important profitability drivers and their relationship over time.

Use Probi AB in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Probi AB position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Probi AB will appreciate offsetting losses from the drop in the long position's value.

Probi AB Pair Trading

Probi AB Pair Trading Analysis

The ability to find closely correlated positions to Probi AB could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Probi AB when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Probi AB - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Probi AB to buy it.
The correlation of Probi AB is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Probi AB moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Probi AB moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Probi AB can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Probi AB position

In addition to having Probi AB in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Apparel Thematic Idea Now

Apparel
Apparel Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Apparel theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Apparel Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Probi Stock Analysis

When running Probi AB's price analysis, check to measure Probi AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Probi AB is operating at the current time. Most of Probi AB's value examination focuses on studying past and present price action to predict the probability of Probi AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Probi AB's price. Additionally, you may evaluate how the addition of Probi AB to your portfolios can decrease your overall portfolio volatility.